EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?

Katia Bravo-Jaimes, Alvaro Whittembury, Vilma Santivañez

International Journal of Nephrology · 2015 · 2015 · 1-6

DOI: 10.1155/2015/568702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nephrology, 2015. Verfasst von Katia Bravo-Jaimes und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of Rochester Medical Center, 601 Elmwood Avenue, Box MED, Rochester, NY 14642, USA ; Facultad de Medicina de San Fernando, Universidad Nac…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Universidad Nacional Mayor de San Marcos.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To determine clinical, biochemical, and pharmacological characteristics as well as cardiovascular disease prevalence and its associated factors among end-stage kidney disease patients receiving hemodialysis in the main hemodialysis center in Lima, Peru.

Methods

This cross-sectional study included 103 patients. Clinical charts were reviewed and an echocardiogram was performed to determine prevalence of cardiovascular disease, defined as the presence of systolic/diastolic dysfunction, coronary heart disease, ventricular dysrhythmias, cerebrovascular disease, and/or peripheral vascular disease. Associations between cardiovascular disease and clinical, biochemical, and dialysis factors were sought using prevalence ratio. A robust Poisson regression model was used to quantify possible associations.

Results

Cardiovascular disease prevalence was 81.6%, mainly due to diastolic dysfunction. It was significantly associated with age older than 50 years, metabolic syndrome, C-reactive protein levels, effective blood flow ≤ 300 mL/min, severe anemia, and absence of mild anemia. However, in the regression analysis only age older than 50 years, effective blood flow ≤ 300 mL/min, and absence of mild anemia were associated.

Conclusions

Cardiovascular disease prevalence is high in patients receiving hemodialysis in the main center in Lima. Diastolic dysfunction, age, specific hemoglobin levels, and effective blood flow may play an important role.

Autor:innen und Institutionen

  • University of Rochester Medical Center, 601 Elmwood Avenue, Box MED, Rochester, NY 14642, USA ; Facultad de Medicina de San Fernando, Universidad Nacional Mayor de San Marcos (UNMSM), Lima, Peru.
  • Facultad de Medicina de San Fernando, Universidad Nacional Mayor de San Marcos (UNMSM), Lima, Peru.

Förderung

  • Universidad Nacional Mayor de San Marcos

Zitieren

APA

Bravo-Jaimes, K., Whittembury, A., & Santivañez, V. (2015). High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?. International Journal of Nephrology, 2015, 1-6. https://doi.org/10.1155/2015/568702

Vancouver

Bravo-Jaimes K, Whittembury A, Santivañez V. High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?. International Journal of Nephrology. 2015;2015:1-6. doi:10.1155/2015/568702

BibTeX
@article{BravoJaimes2015,
  author = {Bravo-Jaimes, Katia and Whittembury, Alvaro and Santivañez, Vilma},
  title = {High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?},
  journal = {International Journal of Nephrology},
  year = {2015},
  volume = {2015},
  pages = {1--6},
  doi = {10.1155/2015/568702}
}
Kostenlos starten →